BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent

BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent - Yahoo Finance

May 29, 2019

BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent Yahoo Finance

Initiation of Phase One Clinical Studies Expected This Year ANN ARBOR, Mich. , May 29, 2019 /PRNewswire/ -- BlueWillow Biologics ® today announced the ...

RSV Treatment

BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent - Yahoo Finance

Comments

Post a Comment

Popular posts from this blog

Analysis | The Keys to Speed in Race for Vaccine, and Its Perils - Washington Post

Prematurity Awareness Month: Educating the public about Respiratory Syncytial Virus is vital, claims leading consultant - ZAWYA

Oishei Children's Hospital Seeing Spike in RSV Cases - Spectrum News